A global database of COVID-19 vaccinations

[Correction Notice: An Erratum for this article was reported in Vol 5(7) of Nature Human Behaviour (see record 2021-69306-023). In the original article, errors occurred in Figs. 2 and 6. Figure 2 showed a lack of alignment between the years presented on gross domestic product (GDP) per capita values across countries. These figures-presented in GDP per capita adjusted for purchasing power parity, measured in international dollars-have now been aligned. This correction was necessary because the most recent year for which GDP data is available from the World Bank is different across countries. The GDP alignment issue will have affected all countries in the dataset, some to a very small (unnoticeable) degree when GDP has not significantly changed year-to-year, but more visibly for countries with strong growth rates (e.g., China). Figure 6 incorrectly indicated that no vaccine for Ebola exists. In fact, the first vaccine against Ebola was approved in the European Union and the USA in 2019. These errors have been corrected in the PDF and HTML versions of this article.] An effective rollout of vaccinations against COVID-19 offers the most promising prospect of bringing the pandemic to an end. We present the Our World in Data COVID-19 vaccination dataset, a global public dataset that tracks the scale and rate of the vaccine rollout across the world. This dataset is updated regularly and includes data on the total number of vaccinations administered, first and second doses administered, daily vaccination rates and population-adjusted coverage for all countries for which data are available (169 countries as of 7 April 2021). It will be maintained as the global vaccination campaign continues to progress. This resource aids policymakers and researchers in understanding the rate of current and potential vaccine rollout;the interactions with non-vaccination policy responses;the potential impact of vaccinations on pandemic outcomes such as transmission, morbidity and mortality;and global inequalities in vaccine access. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

Author correction: A global database of COVID-19 vaccinations

Reports an error in "A global database of COVID-19 vaccinations" by Edouard Mathieu, Hannah Ritchie, Esteban Ortiz-Ospina, Max Roser, Joe Hasell, Cameron Appel, Charlie Giattino and Lucas Rodes-Guirao (Nature Human Behaviour, 2021[Jul], Vol 5[7], 947-953). In the original article, errors occurred in Figs. 2 and 6. Figure 2 showed a lack of alignment between the years presented on gross domestic product (GDP) per capita values across countries. These figures-presented in GDP per capita adjusted for purchasing power parity, measured in international dollars-have now been aligned. This correction was necessary because the most recent year for which GDP data is available from the World Bank is different across countries. The GDP alignment issue will have affected all countries in the dataset, some to a very small (unnoticeable) degree when GDP has not significantly changed year-to-year, but more visibly for countries with strong growth rates (e.g., China). Figure 6 incorrectly indicated that no vaccine for Ebola exists. In fact, the first vaccine against Ebola was approved in the European Union and the USA in 2019. These errors have been corrected in the PDF and HTML versions of this article. (The following of the original article appeared in record 2021-69306-020). An effective rollout of vaccinations against COVID-19 offers the most promising prospect of bringing the pandemic to an end. We present the Our World in Data COVID-19 vaccination dataset, a global public dataset that tracks the scale and rate of the vaccine rollout across the world. This dataset is updated regularly and includes data on the total number of vaccinations administered, first and second doses administered, daily vaccination rates and population-adjusted coverage for all countries for which data are available (169 countries as of 7 April 2021). It will be maintained as the global vaccination campaign continues to progress. This resource aids policymakers and researchers in understanding the rate of current and potential vaccine rollout;the interactions with non-vaccination policy responses;the potential impact of vaccinations on pandemic outcomes such as transmission, morbidity and mortality;and global inequalities in vaccine access. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

A global database of COVID-19 vaccinations.

An effective rollout of vaccinations against COVID-19 offers the most promising prospect of bringing the pandemic to an end. We present the Our World in Data COVID-19 vaccination dataset, a global public dataset that tracks the scale and rate of the vaccine rollout across the world. This dataset is updated regularly and includes data on the total number of vaccinations administered, first and second doses administered, daily vaccination rates and population-adjusted coverage for all countries for which data are available (169 countries as of 7 April 2021). It will be maintained as the global vaccination campaign continues to progress. This resource aids policymakers and researchers in understanding the rate of current and potential vaccine rollout; the interactions with non-vaccination policy responses; the potential impact of vaccinations on pandemic outcomes such as transmission, morbidity and mortality; and global inequalities in vaccine access.

A cross-country database of COVID-19 testing.

Our understanding of the evolution of the COVID-19 pandemic is built upon data concerning confirmed cases and deaths. This data, however, can only be meaningfully interpreted alongside an accurate understanding of the extent of virus testing in different countries. This new database brings together official data on the extent of PCR testing over time for 94 countries. We provide a time series for the daily number of tests performed, or people tested, together with metadata describing data quality and comparability issues needed for the interpretation of the time series. The database is updated regularly through a combination of automated scraping and manual collection and verification, and is entirely replicable, with sources provided for each observation. In providing accessible cross-country data on testing output, it aims to facilitate the incorporation of this crucial information into epidemiological studies, as well as track a key component of countries' responses to COVID-19.